SYNCHRONY FINANCIAL Form 4 Filings

Synchrony Financial executive Amy Tiliakos reported an automatic award of dividend equivalent units linked to existing restricted stock units. On the transaction date, she acquired 59 dividend equivalent units at a reference price of $72.31 per unit, bringing her directly held units to 17,994.

The footnote explains these dividend equivalent units were accrued as dividends paid on the common shares underlying her restricted stock units. They will vest, settle, and expire on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.

Synchrony Financial director Parker P.W. reported an automatic grant related to existing equity awards. On February 17, 2026, Parker acquired 14 dividend equivalent units at a reference price of $72.31 per unit, bringing direct holdings to 32,789 units. These dividend equivalent units were credited as cash dividends were paid on common shares underlying restricted stock units, and they will vest and settle on the same schedule and terms as those restricted stock units. Each unit is economically equal to one share of Synchrony Financial common stock, but follows the vesting and expiration conditions of the related awards.

Synchrony Financial executive Curtis Howse reported an automatic stock sale under a pre-set trading plan. On February 2, 2026, he sold 52,556 shares of Synchrony Financial common stock at $72.32 per share in an open-market sale coded "S."

The filing notes this transaction was made under a Rule 10b5-1 trading plan adopted on July 24, 2025, indicating it was pre-arranged. After the sale, Howse directly owned 94,196 shares of Synchrony Financial common stock and is identified as EVP, CEO--Home & Auto.

Synchrony Financial director Arthur W. Coviello Jr. reported selling 4,000 shares of Synchrony Financial common stock on February 2, 2026. The shares were sold at a price of $72.32 per share in an open-market transaction.

After this sale, Coviello beneficially owns 32,444 shares of Synchrony common stock in direct form. The transaction was carried out under a pre-established Rule 10b5-1 trading plan that he adopted on July 25, 2025, indicating the sales were scheduled in advance rather than decided at the last minute.

Synchrony Financial President and CEO Brian D. Doubles, who also serves as a director, reported equity award activity in company stock. On January 21, 2026, he acquired 390,751 shares of common stock at $77.13 per share in connection with the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program, based on pre-established performance goals for that period.

On the same date, 181,132 shares of common stock at $77.13 per share were withheld by Synchrony Financial to cover his tax liability related to that PSU vesting. After these transactions, Doubles beneficially owned 940,886 shares of Synchrony Financial common stock directly.

Synchrony Financial executive Curtis Howse reported equity compensation activity in company stock. On January 21, 2026, he acquired 67,590 shares of Synchrony Financial common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program based on pre-set performance goals. On the same date, 29,322 shares were withheld by the company, also at $77.13 per share, to cover his tax obligations from this vesting. After these transactions, Howse directly held 146,752 shares of Synchrony Financial common stock.

Synchrony Financial executive Courtney Gentleman reported equity compensation activity tied to performance share units. On January 21, 2026, Gentleman acquired 18,313 shares of Synchrony Financial common stock at $77.13 per share, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals. On the same date, 6,267 shares were withheld by the company at $77.13 per share to cover the related tax liability. Following these transactions, Gentleman directly owned 29,824 shares of Synchrony Financial common stock.

Synchrony Financial executive Bart Schaller, EVP and CEO–Digital, reported equity compensation activity involving the company’s common stock. On January 21, 2026, he acquired 58,939 shares of Synchrony Financial common stock at $77.13 per share. These shares were earned upon the vesting of Performance Share Units granted under the company’s 2023–2025 Long-Term Performance Program, based on pre-established performance goals for that period.

On the same date, 23,638 shares were withheld by Synchrony Financial at a price of $77.13 per share to cover Schaller’s tax obligations related to the PSU vesting. After these transactions, Schaller directly owned 77,425 shares of Synchrony Financial common stock.

Synchrony Financial executive stock activity: Executive Vice President and Chief Financial Officer Brian J. Wenzel reported equity-related transactions in Synchrony Financial common stock on January 21, 2026. He acquired 87,957 shares of common stock at $77.13 per share, earned through the vesting of Performance Share Units under the Company’s 2023–2025 Long-Term Performance Program based on pre-established performance goals for that period. On the same date, 40,845 shares were withheld by Synchrony Financial at $77.13 per share to cover his tax obligations arising from this vesting. Following these transactions, Wenzel directly owned 116,282 shares of Synchrony Financial common stock.

Synchrony Financial executive Darrell Owens reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 15,213 shares of Synchrony Financial common stock at $77.13 per share, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals.

The company withheld 4,909 shares at $77.13 per share to cover Owens’ tax liability related to the PSU vesting. After these transactions, Owens directly held 26,469 shares of Synchrony Financial common stock in his capacity as EVP & CEO--Lifestyle.

Synchrony Financial executive Jonathan S. Mothner, EVP and Chief Risk and Legal Officer, reported stock transactions tied to long-term incentives. On January 21, 2026, he acquired 63,444 shares of Synchrony common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-set performance goals. On the same date, 29,487 shares were withheld by the company at the same price to cover his tax obligations from this vesting. After these transactions, he directly owned 161,057 shares of Synchrony common stock.

Synchrony Financial EVP Alberto Casellas reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 67,590 shares of Synchrony Financial common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program based on pre-established performance goals.

On the same date, 31,870 shares were withheld by the company at $77.13 per share to cover his tax liability from the PSU vesting. After these transactions, Casellas directly owned 92,850 shares of Synchrony Financial common stock in his capacity as EVP, CEO–Health & Wellness.

Synchrony Financial executive equity award activity: EVP, Chief Technology and Operating Officer Carol Juel reported stock transactions tied to long-term incentive compensation. On 01/21/2026, she acquired 79,305 shares of Synchrony common stock, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals. On the same date, 34,894 shares were withheld by the company to cover her tax liability related to this vesting. After these transactions, she held 102,941 shares of Synchrony common stock directly.

Synchrony Financial reported that one of its directors received a new equity grant in the form of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, increasing the director’s beneficial ownership to 32,775 shares held directly after the transaction.

The award is structured as restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, meaning the director must satisfy the vesting conditions before receiving the underlying shares.

Synchrony Financial reported an equity award to one of its directors. On 12/31/2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, reported as an acquisition of common stock. An accompanying note explains that this represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of common stock at vesting. After this transaction, the director beneficially owned 28,562 shares directly and 15,300 shares indirectly through family trusts.

Synchrony Financial director reports equity award in Form 4 filing. A board member received 660 shares of Synchrony Financial common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition. After this transaction, the director beneficially owns 49,755 shares directly.

The award is in the form of restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, so the director’s actual share ownership will increase as these units vest.

Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. After this transaction, the director beneficially owns 3,972 shares of common stock directly.

The 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock. This filing reflects a routine director equity grant rather than an open-market stock purchase or sale.

Synchrony Financial director reported receiving a grant of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. Following this transaction, the director beneficially owns 660 shares directly. The filing notes that these restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of common stock.

Synchrony Financial director reports new stock award. A company director filed details of a stock-based compensation grant involving Synchrony Financial common stock. On 12/31/2025, the director acquired 660 shares in the form of restricted stock units at a value of $83.43 per share. After this grant, the director beneficially owns 16,218 shares of Synchrony Financial common stock in direct ownership.

The filing notes that these 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock.

Synchrony Financial director reports stock grant

A director of Synchrony Financial reported acquiring 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, as shown in a Form 4 filing. Following this transaction, the director beneficially owns 50,411 shares of Synchrony Financial common stock in direct ownership.

The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock at vesting. This reflects routine equity-based compensation rather than an open-market purchase or sale.

Synchrony Financial director reports stock-based award and holdings

A Synchrony Financial director reported receiving 660 shares of common stock as a stock-based award on 12/31/2025 at a price of $83.43 per share. These are in the form of restricted stock units that will vest in full on December 31, 2026, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.

Following this grant, the director beneficially owns 38,734 shares directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, where he is the investment manager and disclaims beneficial ownership except for his direct pecuniary interest.

Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 1,035 shares of Synchrony Financial common stock at a price of $83.43 per share, recorded as an acquisition of non-derivative securities. After this transaction, the director beneficially owned 62,487 shares of Synchrony Financial common stock in direct form.

The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit gives the director a contingent right to receive one share of Synchrony Financial common stock once the vesting date is reached, aligning director compensation with the company’s share performance.

Synchrony Financial director reports stock-based compensation grant. A board member of Synchrony Financial received 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition of non-derivative securities. Following this transaction, the director beneficially owns 36,444 shares of Synchrony Financial common stock in direct ownership.

The grant represents restricted stock units that will vest in full on December 31, 2026, with each unit convertible into one share of Synchrony Financial common stock. This filing reflects routine equity compensation for a director rather than an open-market purchase or sale.

Synchrony Financial reported that one of its directors acquired additional equity through a stock-based award. On December 31, 2025, the director received 660 shares of common stock, shown at a price of $83.43 per share, bringing the director’s directly held beneficial ownership to 30,529 shares after the transaction.

An explanation clarifies that this award represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock when vested. This filing reflects routine director compensation in the form of equity rather than an open-market purchase or sale.

Synchrony Financial (SYF) reported an insider equity accrual for its EVP and CFO on a Form 4. On 11/17/2025, the officer received 294 dividend equivalent units tied to restricted stock units, reflecting dividends paid on the underlying common shares at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.

After this transaction, the reporting person beneficially owned 69,170 common shares or related units on a direct basis.

Synchrony Financial filed a Form 4 reporting a routine equity-related transaction by an officer who serves as SVP, Chief Accounting Officer and Controller. On 11/17/2025, the officer received 61 dividend equivalent units at a value of $70.47 per unit, credited as dividends on common shares underlying restricted stock units. After this transaction, the officer beneficially owned 17,935 non-derivative securities directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock.

Synchrony Financial (SYF) reported a Form 4 filing showing a director acquired additional equity-linked units through routine compensation. On November 17, 2025, the director received 15 dividend equivalent units tied to previously granted restricted stock units, at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the director beneficially owns 32,115 common shares on a direct basis.

Synchrony Financial (SYF) executive reports dividend-related equity awards. On 11/17/2025, an officer serving as EVP, CEO–Health & Wellness reported receiving 213 dividend equivalent units at a reference price of $70.47 per unit, tied to restricted stock units in Synchrony common stock. Following this, the officer beneficially owned 57,130 shares of common stock directly.

The filing also shows acquisition of 0.78 phantom stock units under the Synchrony Financial Deferred Compensation Plan, increasing total phantom stock units beneficially owned to 184.13. Both the dividend equivalent units and phantom stock units are described as economically equivalent to shares of Synchrony common stock, with the phantom units to be settled in cash six months after the officer’s separation from service, in line with plan terms.

Synchrony Financial director reports small increase in equity holdings. A company director of Synchrony Financial (SYF) filed a Form 4 detailing an automatic accrual of dividend equivalent units on November 17, 2025. The filing shows the acquisition of 15 dividend equivalent units at a reference price of $70.47 per unit, linked to previously granted restricted stock units. After this transaction, the reporting person beneficially owns 15,558 SYF shares or equivalents in direct ownership. These dividend equivalent units are economically equal to shares of common stock and will vest and settle on the same schedule and terms as the related restricted stock units.

Synchrony Financial director reported a routine equity-related transaction involving dividend equivalent units tied to restricted stock units. On November 17, 2025, the reporting person accrued 15 dividend equivalent units based on dividends paid on the common shares underlying existing restricted stock units at a referenced value of $70.47 per unit. Each unit is the economic equivalent of one share of Synchrony Financial common stock and will vest, settle, and expire on the same terms as the related restricted stock units.

Following this accrual, the reporting person beneficially owned 27,902 shares of Synchrony Financial common stock directly and 15,300 shares indirectly through family trusts. This reflects ongoing alignment of the director’s interests with shareholders through equity-based compensation rather than a discretionary open-market trade.

Synchrony Financial director Form 4 shows a small equity accrual. A company director reported acquiring 15 dividend equivalent units on 11/17/2025 at a price of $70.47 per unit. These units were credited as dividends on common shares underlying existing restricted stock units.

Following this transaction, the reporting person beneficially owns 29,869 Synchrony Financial common shares on a direct basis. Each dividend equivalent unit is the economic equivalent of one common share and will vest and settle on the same schedule and terms as the related restricted stock units.

Synchrony Financial (SYF) reported an insider equity accrual, as an executive officer acquired 213 dividend equivalent units on 11/17/2025 tied to existing restricted stock units. These units reflect dividends paid on the common shares underlying those awards and are economically equivalent to one share of Synchrony common stock each.

After this transaction, the reporting executive directly beneficially owned 108,484 common shares. The dividend equivalent units will vest and settle on the same schedule and terms as the related restricted stock units. The officer’s title is listed as EVP, CEO--Home & Auto.

Synchrony Financial (SYF) reported a routine insider update for one of its directors. On 11/17/2025, the director acquired 130 dividend equivalent units at $70.47 each. These units were accrued as dividends on the common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. After this transaction, the director beneficially owned 49,095 Synchrony Financial common shares in total.

Synchrony Financial (SYF) reported a small change in insider holdings for an executive. On November 17, 2025, an officer received 249 dividend equivalent units tied to previously granted restricted stock units. These units were valued at $70.47 each and are designed to mirror dividends paid on the underlying common shares.

After this transaction, the officer beneficially owns 58,530 Synchrony Financial common shares directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units and are economically equal to one share of common stock each. The reporting person serves as EVP, Chief Technology and Operating Officer of Synchrony Financial.

A director of Synchrony Financial (SYF) reported the automatic accrual of 15 dividend equivalent units on November 17, 2025. These units were credited as dividends paid on the common shares underlying the director’s restricted stock units. Each dividend equivalent unit is described as the economic equivalent of one share of Synchrony Financial common stock and will vest and settle on the same terms and schedule as the related restricted stock units.

Following this transaction, the director beneficially owns 3,312 Synchrony Financial common shares in direct form. The filing is a routine Form 4 disclosure of equity-based compensation rather than an open-market purchase or sale.

Synchrony Financial EVP reports multiple stock transactions. An executive officer of Synchrony Financial (SYF), serving as EVP, Chief Risk and Legal Officer, reported several transactions dated 11/17/2025. These included 238 dividend equivalent units acquired at $70.47, which mirror restricted stock units, and the sale of 20,000 shares of common stock at $72.80 under a Rule 10b5-1 trading plan adopted on July 28, 2025. The executive also exercised 12,000 employee stock options at $34.30 per share and sold 12,000 shares of common stock at $72.80 on the same date. Following these transactions, the executive directly beneficially owns 127,100 shares of Synchrony Financial common stock and 11,258 employee stock options.

Synchrony Financial director Form 4 filing reports that a board member received 148 dividend equivalent units of Synchrony Financial common stock on November 17, 2025. These units were accrued as dividends on common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan.

Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the reporting person holds 38,074 shares of common stock directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, for which he is investment manager and disclaims beneficial ownership except for his direct pecuniary interest.

Synchrony Financial director reports automatic dividend share equivalents

A director of Synchrony Financial (SYF) reported an automatic accrual of dividend equivalent units on common stock. On November 17, 2025, the reporting person acquired 190 dividend equivalent units at a value of $70.47 per unit. These units relate to dividends paid on common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the reporting person beneficially owned 61,452 common share equivalents, held in a direct capacity.

Synchrony Financial (SYF) executive EVP & CEO--Diversified & Value reported a routine equity-related transaction on Form 4. On 11/17/2025, the officer accrued 76 dividend equivalent units tied to dividends paid on common shares underlying existing restricted stock units, at a referenced value of $70.47 per unit.

After this transaction, the officer beneficially owns 17,778 dividend equivalent units, held directly. These units are economically equivalent to shares of Synchrony common stock and vest, settle, and expire on the same terms as the related restricted stock units, meaning they follow the same schedule and conditions as the original equity awards.

Synchrony Financial (SYF) reported a Form 4 showing a routine equity-related transaction for one of its directors. On November 17, 2025, the director acquired 149 dividend equivalent units, recorded as an acquisition at a price of $70.47 per unit. The filing states that these units were accrued as dividends paid on the common shares underlying previously granted restricted stock units and deferred stock units under the company’s Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan.

Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the director beneficially owns 49,751 common shares directly.

Synchrony Financial (SYF) reported an insider equity change for an executive officer. On 11/17/2025, the EVP, CEO–Digital received 179 dividend equivalent units, recorded as an acquisition. These units were credited at a reference price of $70.47 per unit and are tied to restricted stock units already held.

After this transaction, the reporting person beneficially owned 42,124 Synchrony Financial common share equivalents, held in direct ownership. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock.

Synchrony Financial (SYF) reported a routine insider equity adjustment for an executive officer. On 11/17/2025, the EVP & CEO–Lifestyle received 69 dividend equivalent units, which were accrued as dividends paid on common shares underlying existing restricted stock units.

Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock and was valued at $70.47 per unit for this transaction. These units vest and settle on the same schedule and terms as the related restricted stock units. Following this accrual, the reporting person beneficially owns 16,165 non-derivative securities, held in direct ownership.

Synchrony Financial director reported a small increase in holdings through dividend-related awards. On November 17, 2025, the director received 15 dividend equivalent units tied to previously granted restricted stock units, at a referenced value of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the underlying restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.

Following this transaction, the director beneficially owns 35,784 Synchrony Financial common shares, held directly. The filing is made on Form 4, reflecting routine equity-based compensation in the form of dividend equivalent units rather than an open-market share purchase or sale.

Synchrony Financial’s President and CEO, who also serves as a director, reported an automatic equity-related transaction on a Form 4. On November 17, 2025, the executive accrued 1,197 dividend equivalent units tied to previously granted restricted stock units, at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit represents the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the executive directly beneficially owned 731,267 common share equivalents.

Synchrony Financial (SYF) reported insider activity by an executive officer (EVP & CEO—Lifestyle). On 10/27/2025, 2,377 shares were withheld (Code F) at $72.26 to cover taxes tied to RSU vesting, leaving 19,085 shares owned directly. On 11/03/2025, 2,989 shares were sold (Code S) at $74.02 under a Rule 10b5-1 plan adopted on 10/18/2024, resulting in 16,096 shares owned directly.

Synchrony Financial (SYF) Form 4: An executive reported an internal reallocation involving 11,706 phantom stock units in the company’s Restoration Plan on November 3, 2025. The disposition reflected the $74.01 closing price of SYF common stock on that date.

Phantom stock units are the economic equivalent of one share of common stock and, per plan terms, are settled in cash the month following the six‑month anniversary of the executive’s separation. Following the reported transaction, the filing lists 11,707 phantom stock units beneficially owned in the plan.

The filing indicates a transfer of the cash value to an alternative investment option within the plan, not an open‑market sale of SYF common shares.

Synchrony Financial reported a Form 4 for a director detailing two transactions on 11/03/2025. The insider sold 8,000 shares of common stock at a $73.93 weighted average price, with individual trades ranging from $73.69 to $74.21. The filing also shows a charitable gift of 6,400 shares. These moves were made under a Rule 10b5-1 trading plan adopted on July 25, 2025. Shares beneficially owned following the sale were 35,769.

Synchrony Financial (SYF) reported an insider transaction by an officer (EVP, CEO—Home & Auto) on 11/03/2025. The reporting person exercised 12,086 stock options at $34.30 per share and, the same day, sold 12,086 shares at $74.02. Following these transactions, the officer directly holds 108,271 shares.

The trades were made under a Rule 10b5-1 trading plan adopted on July 24, 2025. The options were originally granted on April 1, 2017 and vest in five equal annual installments, with an expiration date of April 1, 2027.

Daniel O. Colao, a Director of Synchrony Financial (SYF), was reported to have acquired 775 restricted stock units on 09/30/2025 at an implied price of $71.05 per share. After the transaction he beneficially owned 3,297 shares. The filing states these restricted stock units will vest in full on 09/30/2026, and each unit represents the contingent right to one share of common stock. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025. The record shows an insider acquisition of equity-based compensation that converts to common stock upon vesting one year after grant.